Deutsche Bank
VYGR icon

Deutsche Bank’s Voyager Therapeutics VYGR Stock Holding History

Deutsche Bank’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Buy
51,293
+11,263
+28% +$42.7K ﹤0.01% 3312
2026
Q1 		$155K Buy
40,030
+8,361
+26% +$32.9K ﹤0.01% 3104
2025
Q4 		$124K Buy
+31,669
New +$140K ﹤0.01% 3224
2025
Q3 		– Sell
-26,424
Closed -$82.2K – 3744
2025
Q2 		$82.2K Sell
26,424
-10,118
-28% -$32.6K ﹤0.01% 3319
2025
Q1 		$124K Sell
36,542
-5,928
-14% -$27.7K ﹤0.01% 3136
2024
Q4 		$241K Sell
42,470
-35,898
-46% -$231K ﹤0.01% 3015
2024
Q3 		$458K Buy
78,368
+7,720
+11% +$56.1K ﹤0.01% 2510
2024
Q2 		$559K Sell
70,648
-1,259
-2% -$10.6K ﹤0.01% 2279
2024
Q1 		$669K Buy
71,907
+6,121
+9% +$51.7K ﹤0.01% 2208
2023
Q4 		$555K Buy
65,786
+954
+1% +$6.92K ﹤0.01% 2333
2023
Q3 		$502K Sell
64,832
-3,144
-5% -$28.7K ﹤0.01% 2171
2023
Q2 		$778K Buy
67,976
+14,276
+27% +$148K ﹤0.01% 2122
2023
Q1 		$414K Sell
53,700
-1,300
-2% -$10.3K ﹤0.01% 2603
2022
Q4 		$336K Hold
55,000
– – ﹤0.01% 2676
2022
Q3 		$326K Hold
55,000
– – ﹤0.01% 2640
2022
Q2 		$325K Buy
+55,000
New +$372K ﹤0.01% 2863
2021
Q3 		– Sell
-631
Closed -$3K – 4698
2021
Q2 		$3K Sell
631
-26,557
-98% -$120K ﹤0.01% 4538
2021
Q1 		$128K Sell
27,188
-24,428
-47% -$167K ﹤0.01% 3848
2020
Q4 		$369K Sell
51,616
-31,382
-38% -$302K ﹤0.01% 3114
2020
Q3 		$886K Buy
82,998
+31,156
+60% +$366K ﹤0.01% 2279
2020
Q2 		$654K Buy
51,842
+42,414
+450% +$493K ﹤0.01% 2488
2020
Q1 		$86K Sell
9,428
-32,651
-78% -$375K ﹤0.01% 3316
2019
Q4 		$586K Buy
42,079
+30,734
+271% +$447K ﹤0.01% 2647
2019
Q3 		$194K Sell
11,345
-6,707
-37% -$141K ﹤0.01% 3217
2019
Q2 		$490K Sell
18,052
-6,817
-27% -$156K ﹤0.01% 3289
2019
Q1 		$474K Sell
24,869
-121,364
-83% -$1.58M ﹤0.01% 3484
2018
Q4 		$1.37M Buy
146,233
+6,837
+5% +$87.7K ﹤0.01% 2661
2018
Q3 		$2.64M Buy
139,396
+88,049
+171% +$1.69M ﹤0.01% 2669
2018
Q2 		$1M Sell
51,347
-138,793
-73% -$2.74M ﹤0.01% 3416
2018
Q1 		$3.57M Buy
190,140
+150,544
+380% +$3.25M ﹤0.01% 2478
2017
Q4 		$655K Buy
39,596
+26,060
+193% +$447K ﹤0.01% 3463
2017
Q3 		$278K Sell
13,536
-2,495
-16% -$28.2K ﹤0.01% 3715
2017
Q2 		$143K Buy
16,031
+11,987
+296% +$121K ﹤0.01% 4084
2017
Q1 		$52K Sell
4,044
-2,759
-41% -$33.5K ﹤0.01% 4205
2016
Q4 		$85K Buy
6,803
+4,873
+252% +$62.6K ﹤0.01% 4152
2016
Q3 		$23K Buy
1,930
+135
+8% +$1.83K ﹤0.01% 4499
2016
Q2 		$19K Buy
1,795
+924
+106% +$11.3K ﹤0.01% 4770
2016
Q1 		$7K Sell
871
-573
-40% -$6.5K ﹤0.01% 4906
2015
Q4 		$31K Buy
+1,444
New +$33.3K ﹤0.01% 4609

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank's VYGR Position: Q2 2026 in Review

Deutsche Bank increased its Voyager Therapeutics (VYGR) stake by 28% in Q2 2026, buying an estimated $42.7K and bringing the position to 51,293 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

Deutsche Bank first reported a position in VYGR in Q4 2015 and has held it in 39 quarters since. The position peaked at $3.57M in Q1 2018. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Deutsche Bank held 51,293 shares of Voyager Therapeutics worth $180K as of Q2 2026.
  • Deutsche Bank bought 11,263 Voyager Therapeutics shares in Q2 2026, an estimated $42.7K.
  • Voyager Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3312 holding.
  • Deutsche Bank first reported a position in Voyager Therapeutics in Q4 2015 and has held it in 39 quarters since.
  • Deutsche Bank's Voyager Therapeutics position peaked at $3.57M in Q1 2018.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.